Back to search

Spain· ES:1211606001

YSELTY 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

A linzagolix product containing linzagolix, registered in Spain by Theramex Ireland Limited. The same ATC class is registered in 12 of our 19 countries.

ATC H01CC04

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedYSELTY 100 MG COMPRIMIDOS RECUBIERTOS…ATCH01CC04REGISTER NO.ES:1211606001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Linzagolix is registered in 12 of 19 countries.

Countries holding a registration under ATC H01CC04 (linzagolix), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 8 of them publish a price we can compare per daily dose

Linzagolix · ATC H01CC04

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linzagolix costs, country by country.

Normalised to the WHO defined daily dose (0.13 g), so markets compare like for like.

  • Spain: $5.81 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Linzagolix · price per daily dose (0.13 g)

USD · FX 28 Sept 2026

  • IT Italy$6.85
  • ES Spain$5.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)
Active substance
linzagolix
Manufacturer
Theramex Ireland Limited
Country
Spain (ES)
ATC code
H01CC04
ATC class
Linzagolix
Defined daily dose
0.13 g, O
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    762753
    28
    EUR 146.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Linzagolix in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linzagolix products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Yselty
  • Liechtenstein · Yselty
  • Norway · Yselty

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3bfe1955-1072-4c9f-acec-d71780c4669d
GET /v1/drugs/3bfe1955-1072-4c9f-acec-d71780c4669d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1687961292000}",
  "nregistro": "1211606001",
  "substance": "linzagolix"
}

See everything about linzagolix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.